Characteristics and Outcomes of Endometriosis at Dr. M. Djamil Padang General Hospital in 2023

In: Andalas Obstetrics And Gynecology Journal · 2025 · vol. 9(2) , pp. 205–212 · doi:10.25077/aoj.9.2.205-212.2025 · W4412922043
Observational OA: diamond CC0
⚙ AI-generated summary by qwen3.7-flash, 2026-10-01 ⓘ

This 2023 study at Dr. M. Djamil Padang General Hospital found that endometriosis primarily affects nulliparous women of reproductive age with ovarian lesions, achieving a low symptom recurrence rate following leuprolide acetate and dienogest treatment.

One-sentence paraphrase of the abstract; not a substitute for reading it. No clinical advice. How this works

⚙ AI-generated deep summary by qwen3.7-flash, 2026-09-28 · read from full text ⓘ

This descriptive study analyzed the clinical characteristics and treatment outcomes of 129 patients diagnosed with endometriosis at Dr. M. Djamil Padang General Hospital in 2023, with a one-year follow-up on 73 individuals. The cohort was predominantly reproductive-aged, nulliparous women presenting primarily with dysmenorrhea and ovarian lesions, who were largely treated with leuprolide acetate injections. The research found a low symptom recurrence rate of 6.8% and noted that 6.8% of patients achieved pregnancy following the therapeutic interventions. This paper is centrally about endometriosis — specifically detailing the demographic profile, lesion location, and short-term pharmacological outcomes for a single-center patient population.

Read from the paper's body, not the abstract. Not a substitute for reading the paper. No clinical advice. How this works

Abstract

Background. Endometriosis stands as a prevalent benign gynecological condition. It involves the growth of tissue resembling the endometrium outside the uterus, typically impacting the ovaries and peritoneum. Symptoms commonly include premenstrual discomfort and dysmenorrhea. Objective. Knowing the characteristics and outcomes of endometriosis at Dr. M. Djamil Padang General Hospital for the 2023 period. Method. This study is descriptive research aimed at identifying the characteristics of endometriosis among patients at Dr. M. Djamil Padang General Hospital. Conducted in 2023, the study population initially consisted of 129 endometriosis patients. One year later, follow-up was conducted with 73 patients to assess recurrence. Result. There were more patients of reproductive age (97.7%, totaling 126 individuals) than perimenopausal age. The most common complaints reported by patients seeking treatment were dysmenorrhea (81.4%) and non-menstrual abdominal pain (7.8%). The majority of patients were nulliparous (87.6%), followed by multiparous (7%). In terms of BMI categories, most subjects were classified as normal weight (38%) or obese class I (19.4%). Endometriosis lesions were predominantly located in the internal pelvis, particularly in the ovaries (58.1%). Among patients experiencing infertility, the duration was often ≥5 years (31.8%). Nearly all patients received a three-month course of leuprolide acetate injections (97.3%), with additional therapy involving dienogest tablets for three months in 38.4% of cases. Recurrence of symptoms occurred in only 6.8% of patients, while 6.8% of patients became pregnant following treatment. Conclusion. This study concludes that the incidence of endometriosis is high in women of reproductive age. Providing good education about endometriosis is important in order to reduce the delay in diagnosis of this disease so that it can be treated when the stadium was still mild.
Full text 5,684 characters · extracted from oa-doi-fallback · click to expand
Characteristics and Outcomes of Endometriosis at Dr. M. Djamil Padang General Hospital in 2023 DOI: https://doi.org/10.25077/aoj.9.2.205-212.2025Keywords: Characteristics, Outcomes, EndometriosisAbstract Background. Endometriosis stands as a prevalent benign gynecological condition. It involves the growth of tissue resembling the endometrium outside the uterus, typically impacting the ovaries and peritoneum. Symptoms commonly include premenstrual discomfort and dysmenorrhea. Objective. Knowing the characteristics and outcomes of endometriosis at Dr. M. Djamil Padang General Hospital for the 2023 period. Method. This study is descriptive research aimed at identifying the characteristics of endometriosis among patients at Dr. M. Djamil Padang General Hospital. Conducted in 2023, the study population initially consisted of 129 endometriosis patients. One year later, follow-up was conducted with 73 patients to assess recurrence. Result. There were more patients of reproductive age (97.7%, totaling 126 individuals) than perimenopausal age. The most common complaints reported by patients seeking treatment were dysmenorrhea (81.4%) and non-menstrual abdominal pain (7.8%). The majority of patients were nulliparous (87.6%), followed by multiparous (7%). In terms of BMI categories, most subjects were classified as normal weight (38%) or obese class I (19.4%). Endometriosis lesions were predominantly located in the internal pelvis, particularly in the ovaries (58.1%). Among patients experiencing infertility, the duration was often ≥5 years (31.8%). Nearly all patients received a three-month course of leuprolide acetate injections (97.3%), with additional therapy involving dienogest tablets for three months in 38.4% of cases. Recurrence of symptoms occurred in only 6.8% of patients, while 6.8% of patients became pregnant following treatment. Conclusion. This study concludes that the incidence of endometriosis is high in women of reproductive age. Providing good education about endometriosis is important in order to reduce the delay in diagnosis of this disease so that it can be treated when the stadium was still mild. References 1. Allaire C, Bedaiwy MA, Yong PJ. Diagnosis and management of endometriosis. CMAJ. 2023 Mar 14;195(10):E363-E371. DOI:10.1503/cmaj.220637 2. Anastasilakis AD, Polyzos SA, Vorkas PA, Gkiomisi A, Yavropoulou MP, et.al. Lipid Profile after Pharmacologic Discontinuation and Restoration of Menstruation in Women with Endometriosis: A 12-Month Observational Prospective Study. J Clin Med. 2023 Aug 21;12(16):5430. DOI:10.3390/jcm12165430 3. Diagnosis of endometriosis in the 21st century. Kiesel L, Sourouni M. Climacteric. 2019;22:296–302. DOI:10.1080/13697137.2019.1578743 4. Hoffman. Endometriosis. In: Williams Gynecology. 3rd ed. New York: Mc Graw Hill Education; 2016. p.230-48 5. Hidayat A, Hendry D. Karakteristik penderita endometriosis dan adenomiosis di RSUP Dr. M. Djamil padang periode januari 2017-oktober 2018. Andalas Obstetrics and Gynecology Journal. 2019; 3: 28-41.45. 6. Marhenriyanto W, Hendry D. Comparison of pain scale in patients with endometriosis cysts and adenomyosis before surgery, after surgery and after giving analog GnRH. Andalas Obstetrics and Gynecology Journal. 2020; 4.1:35-47. 7. Origins and progression of adolescent endometriosis. Brosens I, Gargett CE, Guo SW, Puttemans P, Gordts S, Brosens JJ, Benagiano G. Reprod Sci. 2016;23:1282–1288. DOI:10.1177/1933719116637919 8. Callahan. Endometriosis and adenomyosis. In: Blueprints Obstetrics and Gynecology. 6th ed. Philadelphia: Lippincott Williams and Wilkins; 2013. p.204-14 9. Endometriosis and infertility: epidemiology and evidence-based treatments. Ozkan S, Murk W, Arici A. Ann N Y Acad Sci. 2008;1127:92–100. DOI:10.1196/annals.1434.007 10. Fritz M, Speroff L. Endometriosis. In: Clinical gynecologic endocrinology and infertility. 8th ed. Philadelphia: Lippincott William & Wilkin; 2011. p.1221-48 11. Oocyte quality is decreased in women with minimal or mild endometriosis. Xu B, Guo N, Zhang XM, Shi W, Tong XH, Iqbal F, Liu YS. Sci Rep. 2015;5:10779. DOI:10.1038/srep10779 12. Lindsay SF, Luciano DE, Luciano AA. Emerging therapy for endometriosis. Expert opinion on emerging drugs. 2015;20(3):449-61. 13. Parazzini F, Esposito G, Tozzi L, Noli S, Bianchi S. Epidemiology of endometriosis and its comorbidities. European Journal Obstetrics & Gynecology Reproductive Biology. 2016; 209: 3-7. 14. Advincula A, Truong M, Lobo RA. Endometriosis: etiology, pathology, diagnosis, management. . Coprehensive Gynecology. 7th ed. Philadelphia: Mosby Elsevier; 2017. p. 423-42 15. Lee HJ, Park YM, Jee BC, Kim YB, Suh CS. Various anatomic locations of surgically proven endometriosis : A single-center experience. Obstetrics & Gynecology Science. 2015; 58: 53-8. DOI:10.5468/ogs.2015.58.1.53 16. Tissot M, Lecointre L, Faller E, Afors K, Akladios C, Audebert A. Clinical presentation of endometriosis identified at interval laparoscopic tubal sterilization: Prospective series of 465 cases. J Gynecol Obstet Hum Reprod. 2017;1-4 17. Anastasilakis AD, Polyzos SA, Vorkas PA, Gkiomisi A, Yavropoulou MP, et.al. Lipid Profile after Pharmacologic Discontinuation and Restoration of Menstruation in Women with Endometriosis: A 12-Month Observational Prospective Study. J Clin Med. 2023 Aug 21;12(16):5430. 18. Kelley A, Moravek M. Diagnosis and management of endometriosis. In: Handbook of Gynecology. Los Angeles: Springer; 2017. p.281-90 Downloads Published How to Cite Issue Section License Copyright (c) 2025 Fahrur Rozi Illahi, Mondale Saputra, Haviz Yuad This work is licensed under a Creative Commons Attribution 4.0 International License.

Text is read by the "Ask this paper" AI Q&A widget below. Extraction quality varies by source — PMC NXML preserves structure cleanly, OA-HTML may include some navigation residue, and OA-PDF can have broken hyphenation. The publisher copy (via DOI) is the canonical version.

My notes (saved in your browser only)

⚙ Ask this paper AI returns verbatim quotes from the full text · source: oa-doi-fallback ⓘ

Answers must be backed by verbatim quotes from this paper's full text. Hallucinated quotes are dropped automatically; if no verbatim passage answers the question, we say so. How this works

Condition tags

endometriosisdysmenorrheainfertility

Citation neighborhood (no data yet)

We don't have any in-corpus citations linked to this paper yet. This is a recent paper (2025) — citers typically take a year or two to land, and the OpenAlex reference graph may still be filling in.

Source provenance

openalex
last seen: 2026-06-10T17:14:06.276822+00:00
License: CC0 · commercial use OK